Marketwise (NASDAQ:MKTW) Stock, Quote.Headers.trade-ideas

Marketwise

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADXN

ATNI

BIVI

BOOM

ENSC

GNPX

ALPS ETF Trusthen & Steers Global Realty Majors ETF

INAB

IRTC

KSCP

MEDP

MKTW

NTBL

SNSE

TCBP

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Pre-market: 5 titoli da monitorare oggi, 13 agosto 2024

Long Ideas

RILY

Top 3 Financials Stocks Which Could Rescue Your Portfolio This Month

Stress,Business,Man,Look,At,The,Computer,Screen,,The,Red

Legal

Management

Porter Stansberry resigns as chairman and CEO of MarketWise, causing a 25% drop in stock.

MarketWise Drops Over 25% After CEO Resigns: Sale Of His Porter &amp; Co. To Company &#39;Like Trying To Share A Ham Sandwich With A Pit Bull&#39;

Marketwise Inc

C3.Ai Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) shares are trading lower Tuesday on the heels of the company&#8217;s second-quarter financial results. Multiple analysts adjusted price targets following the print. Here&#8217;s what <a href="https://www.benzinga.com/news/earnings/24/12/42400744/c3ai-stock-rallies-after-q2-results-seventh-consecutive-quarter-of-accelerating-revenue-growth">you need to know</a>. 
What Happened: C3.AI reported second-quarter revenue of $93.34 million, beating analyst estimates of $91.02 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported a quarterly loss of 6 cents per share, beating analyst estimates for a loss of 16 cents per share. 
Shares initially raced higher on the release, likely buoyed by the company&#8217;s new global alliance agreement with Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). C3.AI said it signed a new agreement with an initial five-and-a-half-year term with Microsoft to accelerate growth in enterprise AI.
&#8220;It is difficult to overstate the potential of the Microsoft–C3 AI strategic alliance. By establishing C3 AI as a preferred AI application provider on Azure and creating a Microsoft-scale go-to-market engine, we&#8217;re making it easy for businesses to adopt and deploy C3 AI applications. This is an inflection point for Enterprise AI, driving growth,&#8221; said Thomas Siebel, chairman and CEO of C3.AI.
C3.AI said it expects third-quarter revenue to be in the range of $95.5 million to $100.5 million versus estimates of $97.57 million. The company expects full-year revenue to be between $378 million and $398 million versus estimates of $382.57 million, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Check This Out: <a href="https://www.benzinga.com/24/12/42405142/nvidia-amd-c3-ai-oracle-tesla-why-these-5-stocks-are-on-investors-radars-today">Nvidia, AMD, C3 ai, Oracle, Tesla: Why These 5 Stocks Are On Investors&#8217; Radars Today?</a>
Shares reversed course in early trading Tuesday despite multiple price target increases rolling in. Multiple analysts maintained Neutral or Underweight ratings. Here&#8217;s a look at the analyst reactions to earnings. 
<ul>
<li>Piper Sandler analyst Arvind Ramnani maintained C3.AI with a Neutral and raised the price target from&nbsp;$24&nbsp;to&nbsp;$42.</li>
</ul>
<ul>
<li>Needham analyst Mike Cikos reiterates C3.ai with a <a href="https://www.benzinga.com/analyst-stock-ratings">Hold rating</a>.</li>
</ul>
<ul>
<li>Morgan Stanley analyst Sanjit Singh maintained C3.AI with an Underweight and raised the price target from&nbsp;$21&nbsp;to&nbsp;$32.</li>
</ul>
<ul>
<li>Northland Capital Markets analyst Michael Latimore maintained C3.AI with an Outperform and raised the price target from&nbsp;$35&nbsp;to&nbsp;$45.</li>
</ul>
AI Price Action: <a href="http://benzinga.com/quote/ai">C3.AI shares</a> were down 9.78% at $37.61 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Earnings

Price Target

MSFT

What's Going On With C3.AI Stock Tuesday?

Compass Point analyst David Rochester maintains BankUnited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKU#NYSE">BKU</a>) with a Buy and raises the price target from $42 to $49.

Analyst Ratings

Compass Point Maintains Buy on BankUnited, Raises Price Target to $49

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 150 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.36% to 44,242.81 while the NASDAQ rose 0.43% to 19,820.91. The S&amp;P 500 also fell, dropping, 0.01% to 6,052.43.
Check This Out: <a href="https://www.benzinga.com/24/12/42413544/how-to-earn-500-a-month-from-macys-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Macy&#8217;s Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Communication services shares jumped by 2.3% on Tuesday.
In trading on Tuesday, utilities shares fell by 1.1%.
Top Headline
Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) posted weaker-than-expected earnings and sales results for its second quarter on Monday.
The company reported second-quarter revenue of $14.06 billion, up 9% year-over-year. The revenue total missed a Street consensus estimate of $14.11 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Chimerix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMRX#NASDAQ">CMRX</a>) shares shot up 172% to $2.36 after the company announced it will submit dordaviprone for accelerated approval to the FDA for patients with recurrent H3 K27M-mutant diffuse glioma.</li>
<li>Shares of Cumberland Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPIX#NASDAQ">CPIX</a>) got a boost, surging 112% to $2.6400 after the company announced the FDA has approved its supplemental new drug application for acetadote.</li>
<li>uniQure N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) shares were also up, gaining 104% to $15.00 after the company announced an agreement with the FDA on key elements of an accelerated pathway for AMT-130.</li>
</ul>
Equities Trading DOWN
<ul>
<li>CervoMed Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) shares dropped 75% to $2.54 after the company announced its Phase 2b trial of Neflamapimod failed to meet its key endpoints for the treatment of dementia.</li>
<li>Shares of Biora Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOR#NASDAQ">BIOR</a>) were down 44% to $0.7499.</li>
<li>MEDIROM Healthcare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) was down, falling 41% to $1.65. MEDIROM Healthcare priced its $5 million public offering of 2.86 million American Depositary Shares at $1.75 per ADS.</li>
</ul>
Commodities In commodity news, oil traded up 0.1% to $68.40 while gold traded up 1% at $2,712.20.
Silver traded up 0.4% to $32.750 on Tuesday, while copper fell 0.6% to $4.2500.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.2%, Germany's DAX rose 0.2% and France's CAC 40 fell 0.6%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 fell 0.6%.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei 225 gaining 0.18%, Hong Kong's Hang Seng Index gaining 2.76%, China's Shanghai Composite Index falling 0.05% and India's BSE Sensex falling 0.25%.
Economics
U.S. nonfarm business sector labor productivity increased by 2.2% in the third quarter, in-line with the preliminary reading.&nbsp;&nbsp;&nbsp;&nbsp;
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42412458/amazon-to-rally-around-15-here-are-10-top-analyst-forecasts-for-tuesday">Amazon To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday</a></li>
</ul>

Equities

Eurozone

Commodities

BIOR

CMRX

CPIX

CRVO

ORCL

QURE

Dow Falls 150 Points; Oracle Posts Downbeat Results

Compass Point analyst David Rochester maintains American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) with a Neutral and raises the price target from $260 to $315.

Compass Point Maintains Neutral on American Express, Raises Price Target to $315

Whales with a lot of money to spend have taken a noticeably bullish stance on Alphabet.
Looking at options history for Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) we detected 59 trades.
If we consider the specifics of each trade, it is accurate to state that 57% of the investors opened trades with bullish expectations and 23% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $117,380 and 57, calls, for a total amount of $3,153,290.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $155.0 to $200.0 for Alphabet over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Alphabet options trades today is 18163.43 with a total volume of 360,470.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Alphabet's big money trades within a strike price range of $155.0 to $200.0 over the last 30 days.
<h3>Alphabet Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733842018_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$11.25</td>
<td>$11.2</td>
<td>$11.25</td>
<td>$175.00</td>
<td>$214.8K</td>
<td>18.3K</td>
<td>695</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.0</td>
<td>$4.9</td>
<td>$5.0</td>
<td>$185.00</td>
<td>$131.5K</td>
<td>23.8K</td>
<td>1.2K</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$1.64</td>
<td>$1.59</td>
<td>$1.6</td>
<td>$185.00</td>
<td>$126.4K</td>
<td>9.6K</td>
<td>30.7K</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/13/24</td>
<td>$7.75</td>
<td>$7.35</td>
<td>$7.75</td>
<td>$175.00</td>
<td>$116.2K</td>
<td>16.7K</td>
<td>878</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$11.05</td>
<td>$10.75</td>
<td>$11.0</td>
<td>$175.00</td>
<td>$96.8K</td>
<td>18.3K</td>
<td>387</td>
</tr>
</tbody>
</table>

<h3>About Alphabet</h3>
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV, YouTube Music among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform, or GCP, accounts for roughly 10% of Alphabet's revenue with the firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) making up the rest.
Having examined the options trading patterns of Alphabet, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Alphabet</h3>
<ul>
<li>Currently trading with a volume of 5,299,714, the GOOGL's price is up by 4.2%, now at $182.74. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 49 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Alphabet, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

GOOGL

Spotlight on Alphabet: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMZN, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Amazon.com.
This isn't normal.
The overall sentiment of these big-money traders is split between 55% bullish and 22%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $87,400, and 6 are calls, for a total amount of $281,340.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $195.0 to $230.0 for Amazon.com during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Amazon.com stands at 11360.71, with a total volume reaching 9,526.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Amazon.com, situated within the strike price corridor from $195.0 to $230.0, throughout the last 30 days.
<h3>Amazon.com Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733842013_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$52.55</td>
<td>$48.6</td>
<td>$50.8</td>
<td>$230.00</td>
<td>$101.6K</td>
<td>935</td>
<td>20</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$13.0</td>
<td>$12.9</td>
<td>$13.0</td>
<td>$215.00</td>
<td>$48.1K</td>
<td>27.5K</td>
<td>48</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$5.1</td>
<td>$5.05</td>
<td>$5.1</td>
<td>$225.00</td>
<td>$42.8K</td>
<td>15.6K</td>
<td>129</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$1.6</td>
<td>$1.59</td>
<td>$1.59</td>
<td>$230.00</td>
<td>$31.8K</td>
<td>21.3K</td>
<td>2.8K</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$2.13</td>
<td>$2.08</td>
<td>$2.12</td>
<td>$225.00</td>
<td>$31.8K</td>
<td>9.0K</td>
<td>3.1K</td>
</tr>
</tbody>
</table>

<h3>About Amazon.com</h3>
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.
Following our analysis of the options activities associated with Amazon.com, we pivot to a closer look at the company's own performance.
<h3>Amazon.com's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,192,827, the price of AMZN is down by -0.03%, reaching $226.03.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 51 days from now.</li>
</ul>
<h3>What The Experts Say On Amazon.com</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $248.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from MoffettNathanson continues to hold a Buy rating for Amazon.com, targeting a price of $248. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for Amazon.com, targeting a price of $260. 
&#x2A; An analyst from Roth MKM persists with their Buy rating on Amazon.com, maintaining a target price of $250. 
&#x2A; In a cautious move, an analyst from BMO Capital downgraded its rating to Outperform, setting a price target of $236. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $250.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Amazon.com, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

AMZN

This Is What Whales Are Betting On Amazon.com

Deep-pocketed investors have adopted a bearish approach towards Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AVGO usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Broadcom. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 9% leaning bullish and 72% bearish. Among these notable options, 2 are puts, totaling $223,905, and 9 are calls, amounting to $693,429.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $76.0 to $180.0 for Broadcom during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Broadcom's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Broadcom's significant trades, within a strike price range of $76.0 to $180.0, over the past month.
<h3>Broadcom Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733842007_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$14.35</td>
<td>$14.15</td>
<td>$14.4</td>
<td>$175.00</td>
<td>$358.4K</td>
<td>860</td>
<td align="right">262</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$4.6</td>
<td>$4.55</td>
<td>$4.6</td>
<td>$170.00</td>
<td>$195.4K</td>
<td>5.5K</td>
<td align="right">478</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$33.25</td>
<td>$33.15</td>
<td>$33.15</td>
<td>$175.00</td>
<td>$66.3K</td>
<td>273</td>
<td align="right">20</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/13/24</td>
<td>$18.1</td>
<td>$17.3</td>
<td>$17.7</td>
<td>$160.00</td>
<td>$53.1K</td>
<td>1.0K</td>
<td align="right">159</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/24/25</td>
<td>$10.3</td>
<td>$10.0</td>
<td>$10.0</td>
<td>$180.00</td>
<td>$50.0K</td>
<td>250</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Broadcom</h3>
Broadcom is the sixth-largest semiconductor company globally and has expanded into various software businesses, with over $30 billion in annual revenue. It sells 17 core semiconductor product lines across wireless, networking, broadband, storage, and industrial markets. It is primarily a fabless designer but holds some manufacturing in-house, like for its best-of-breed FBAR filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments.Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as Brocade, CA Technologies, and Symantec in software.
<h3>Where Is Broadcom Standing Right Now?</h3>
<ul>
<li>With a trading volume of 473,457, the price of AVGO is down by -0.79%, reaching $177.53.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 2 days from now.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Broadcom with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

AVGO

A Closer Look at Broadcom's Options Market Dynamics

RBC Capital analyst Gregory Renza reiterates Jazz Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) with a Outperform and maintains $179 price target.

Reiteration

JAZZ

RBC Capital Reiterates Outperform on Jazz Pharmaceuticals, Maintains $179 Price Target

After listing his $13.7M Long Island home and announcing &#8220;I am done&#8221; with New York earlier, the Wall Street Journal reports that <a href="https://www.benzinga.com/topic/fox-news">Fox News</a> host Sean Hannity has purchased a Florida estate for<a href="https://www.wsj.com/real-estate/luxury-homes/after-leaving-new-york-sean-hannity-pays-23-5-million-for-florida-estate-1f5bfa49"> </a>$23.5 million.
In the upscale town of Manalapan, Palm Beach County, Hannity's new home was initially listed for $29 million in February. The seller – an executive with ties to hedge fund Alden Global Capital – made a tidy sum on the sale, having purchased the home in 2021 for $18 million.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
</ul>
<h2 class="wp-block-heading">A $23M Teardown</h2>
The two-acre estate is located on Barrier Island and enjoys frontage on the Atlantic Ocean and Intracoastal Waterway, with a large dock. The roughly 12,000-square-foot, 8-bedroom home features a pool, wine room and rooftop observation terrace. Despite the price, the home&#8217;s interior is somewhat dated and would likely undergo a major renovation or even a teardown for a more modern structure, as is common in the area. The luxurious town of Manalapan has seen many high-priced deals recently, highlighted by Oracle cofounder <a href="https://www.benzinga.com/topic/larry-ellison">Larry Ellison</a>&#8216;s record-setting $173 million oceanfront estate purchased in 2022.
<h2 class="wp-block-heading">Hannity&#8217;s Real Estate Empire</h2>
Hannity is no novice when it comes to real estate. The outspoken conservative, known for his hard-core interviewing style, is equally aggressive in real estate, amassing a fortune in investments, often hidden behind shell companies and spread across multiple states, as previously reported in the Guardian and LA Times.&nbsp;
See Also: Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
According to these reports, Hannity's shell companies all start with the same four letters, &#8220;SPMK,&#8221; followed by Roman numerals. The companies spent at least $90m on more than 870 homes in seven states. Many were bought at a discount in 2013 after banks foreclosed on their previous owners for mortgage defaulting. The properties range from luxurious mansions to rentals for low-income families.
Among the varied portfolio is an entire neighborhood of duplexes in Lithia Springs, Ga.; apartment complexes<a href="http://www.seasonsathens.com/"> </a>in Athens, Ga.; Brunswick, Ga.; Gainesville, Ga. and Madison, Ala.; high-rise condos in South Florida and a private helicopter and jet registered at an airport 20 miles from his former Long Island home.&nbsp;
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
Hannity makes no secret of his extensive holdings and previously stated on his website: "It is ironic that I am being attacked for investing my personal money in communities that badly need such investment and in which, I am sure, those attacking me have not invested their money,&#8221; Hannity said in a statement on his website. &#8220;The fact is, these are investments I do not individually select, control or know the details about, except that obviously, I believe in putting my money to work in communities that otherwise struggle to receive such support.&#8221;&nbsp;
Hannity is among many high-net-worth celebrities in Manalapan, including Larry Ellison, musician Billy Joel and self-help guru <a href="https://www.benzinga.com/general/24/02/37241630/the-holy-grail-of-investing-author-explains-how-you-could-turn-100-000-into-13-9-million-and-make-50">Tony Robbins</a>.
Read Next:
<ul>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

Fox TV's Sean Hannity Trades New York For A $23.5 Million Florida Estate, The Latest Addition To His Expansive Real Estate Portfolio

Goldman Sachs analyst Brooke Roach maintains Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) with a Buy and raises the price target from $20 to $26.

WRBY

Goldman Sachs Maintains Buy on Warby Parker, Raises Price Target to $26

GELS

Gelteq Limited Shares Halted To The Upside; Stock Now Up 49.44%

Ferguson Enterprises Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) shares are trading lower after <a href="https://www.benzinga.com/pressreleases/24/12/b42408961/ferguson-reports-first-quarter-results" target="_blank" rel="noreferrer noopener">the company reported first-quarter results</a>.
The company reported&nbsp;net sales of&nbsp;$7.77&nbsp;billion, which was&nbsp;0.8% higher year over year, missing the consensus of&nbsp;$7.83 billion.
Organic revenue fell by&nbsp;0.3%, with a&nbsp;1.1%&nbsp;negative impact from acquisition growth. Net sales in the U.S. business increased by&nbsp;0.5%, while&nbsp;that in Canada grew by 6.3%.
Gross margin contracted by 10 basis points to&nbsp;30.1% in the&nbsp;first quarter. Adjusted operating margin contracted to 9.1% from 10% a year ago quarter.
Adjusted EBITDA declined to&nbsp;$758 million from $819 million a year ago quarter. Adjusted EPS&nbsp;of&nbsp;$2.45, missing <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the consensus of&nbsp;$2.62</a>.
The company declared a quarterly dividend per share of&nbsp;$0.83, representing a growth of 5% over prior year. The dividend will be paid on February 6 to stockholders of record as of December 20, 2024.
Ferguson repurchased shares worth&nbsp;$256&nbsp;million&nbsp;in the quarter, with around $600 million remaining under the current share repurchase program.
Outlook Reiterated:&nbsp;Ferguson expects FY25 net sales growth to be in low-single-digits, adjusted operating margin of&nbsp;9.0%&nbsp;–&nbsp;9.5%, and capital expenditures of&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$400 million&nbsp;–&nbsp;$450 million</a>.
Kevin Murphy, Ferguson CEO, said, &#8220;While we anticipate an ongoing challenging near term market environment, we will continue to invest in scale and capabilities to take advantage of multi-year structural tailwinds such as underbuilt and aging U.S. housing, non-residential large capital projects and our opportunity with the plumbing and HVAC specialized professional.&#8221;
Investors can gain exposure to the stock via&nbsp;Invesco Water Resources ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHO#NASDAQ">PHO</a>) and&nbsp;Global X Clean Water ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQWA#NASDAQ">AQWA</a>).
Price Action:&nbsp;FERG shares are down 9.82% at $196.36 at the last check Tuesday.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com//node/42412064" target="_blank" rel="noreferrer noopener">BlackBerry And TTTech Auto Unveil Key Solution For Safer, Smarter Cars</a></li>
</ul>

Large Cap

Guidance

AQWA

FERG

PowerShares Exchange Traded Fund Water Resource Portfolio

Ferguson Maintains FY25 Guidance Amid Tough Market, Q1 Misses Estimates

Metagenomi Shares Halted To The Downside; Stock Now Down -1.20%

Goldman Sachs analyst Neil Mehta maintains PBF Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) with a Neutral and lowers the price target from $38 to $34.

Goldman Sachs Maintains Neutral on PBF Energy, Lowers Price Target to $34

BMO Capital analyst Kenneth Lee downgrades BrightSphere Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSIG#NYSE">BSIG</a>) from Outperform to Sector Perform and raises the price target from $30 to $33.

Downgrades

BrightSphere Investment Group plc Ordinary Shares

BSIG

BMO Capital Downgrades BrightSphere Investment to Sector Perform, Raises Price Target to $33

Biotech

General

IMMX

Immix Biopharma Reports 75% Complete Response Rate And 31.5-Month Ongoing Best Response Duration For CAR-T NXC-201 In Relapsed/Refractory AL Amyloidosis At ASH 2024, Highlighting Phase 1/2 Data With Median Four Prior Therapy Lines

On Monday, Chimerix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMRX#NASDAQ">CMRX</a>) announced that, following extensive dialogue with the FDA, the company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone for recurrent H3 K27M-mutant diffuse glioma in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42399560/chimerix-to-submit-dordaviprone-for-accelerated-approval-to-u-s-fda-for-patients-with-recurrent-h3" rel="noreferrer noopener">the U.S. before year-end</a>.
A glioma is&nbsp;a tumor that originates in the glial cells of the brain or spinal cord and is the most common primary brain tumor.
Chimerix stock is trading higher on a strong session volume of 4.31 million, compared to an average volume of 497.04K, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
The following recent program milestones and additional supportive data were extensively discussed with the FDA and will be included in the NDA:
<ul>
<li>Substantial enrollment of the Phase 3 ACTION study.</li>
<li>Phase 2 objective response rate of the 50-patient primary efficacy analysis as the primary basis of efficacy in the NDA.</li>
<li>Several response assessments, under which dordaviprone demonstrated an objective response rate of 28%, a median duration of response of 10.4 months, and a median time to response of 4.6 months.</li>
<li>Additional clinical data sets and patient narratives supportive of the primary efficacy analysis.</li>
<li>Clinical and nonclinical demonstration of dordaviprone-driven reversal of the central hallmark of H3 K27M-mutant glioma, H3K27 trimethyl loss.</li>
<li>Comprehensive safety database of glioma patients and healthy volunteers that supports a favorable benefit/risk profile.</li>
<li>Comprehensive clinical pharmacology and chemistry, manufacturing, and controls (CMC) studies.</li>
</ul>
Chimerix will request a Priority Review for the NDA. If granted, the resulting six-month FDA review period is expected to result in a potential initial Prescription Drug User Fee Act (PDUFA) action date in the third quarter of 2025.
Dordaviprone has received Rare Pediatric Disease Designation for H3 K27M-mutant glioma and is eligible to apply for a Rare Pediatric Disease Priority Review Voucher.
&#8220;In anticipation of a potential approval, we have bolstered our commercial leadership team and will be ready for a U.S. launch as early as the third quarter of 2025, pending application acceptance and Priority Review, if granted,&#8221; said Mike Andriole, CEO of Chimerix.
Price Action: CMRX stock is up 153.20% at $2.19 at last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42397286/biogen-downgraded-on-pipeline-setbacks-and-leqembi-sales-slowdown" target="_blank" rel="noreferrer noopener">Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown</a></li>
</ul>

Health Care

Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?

SATL

Satellogic Shares Halted To The Downside; Stock Now Down -20.25%

VSTS

Advent, Apollo Among Buyout Firms That Are Bidding For Vestis

Ohio Supreme Court Sides With CVS , Walmart And Walgreens In Appeal Of $650.9M Opioid Trial Judgement

Warning: MKTW is at high risk of performing badly

MarketWise (MKTW) has provided an announcement. Chad Curlett, the Chief Operating Officer of MarketWise, Inc., resigned on August 19, 2024, and fin...

MarketWise COO Chad Curlett Resigns with Severance Deal

With solid financial performance, strategic alliances, and a unified platform for advanced data protection and cyber resilience, is Commvault Systems (CVLT) poised to be the next big player in cloud security? Read more to find out... Commvault Systems, Inc. (<a href="https://stocknews.com/stock/CVLT/">CVLT</a>) is the gold standard in cyber resilience, safeguarding data for over 100,000 organizations and ensuring their businesses remain resilient and thrive. It provides innovative security and AI features to protect data from cyber threats, modern backup and recovery capabilities, and integration with top cloud providers and security partners.
CVLT reported better-than-expected first-quarter 2024 results. Commvault's total revenue came in at $224.70 million, surpassing analysts' estimate of $215.54 million. Moreover, CVLT recorded a 17% annualized recurring revenue (ARR) year-over-year growth to $803 million, and its subscription ARR rose to $636 million, up 28% year-over-year.
In addition, the company posted non-GAAP net income per share of $0.85, compared to the consensus estimate of $0.73.
Furthermore, Commvault provided updated guidance for the fiscal year 2025. The company expects its total revenues to be between $915 million and $925 million. Its total ARR is expected to increase 15% year-over-year. Its subscription revenue is anticipated to be between $522 million and $527 million, and subscription ARR will grow 23%-25% year-over-year.
For the 13th consecutive time, CVLT was <a href="https://community.commvault.com/news-events-7/13-times-a-gartner-magic-quadrant-leader-for-enterprise-backup-and-recovery-software-solutions-9300">positioned by Gartner as a Leader in the 2024 Magic Quadrant</a> for Enterprise Backup and Recovery Software Solutions based on its completeness of vision and ability to execute. Also, Commvault had been named a "Leader" and "Forward Mover" in the <a href="https://www.commvault.com/gc/gigaom-sonar-report-for-cloud-based-data-protection#:~:text=Commvault%20Named,Forward%20Mover%E2%80%8B&amp;text=The%202024%20GigaOm%20Sonar%20for,leaderboard%20among%2013%20competing%20vendors.">2024 GigaOm Sonar Report</a> for Cloud-Native Data Protection.
Shares of CVLT have gained 57.9% over the past six months and 119.9% over the past year to close the last trading session at $150.41. Also, the stock has surged 20.2% over the past month.
Let's look at factors that could influence CVLT's performance in the upcoming months.
Positive Recent Developments
On August 5, CVLT announced an <a href="https://www.commvault.com/news/commvault-expands-cybersecurity-ecosystem-with-leading-integration-partners#:~:text=TINTON%20FALLS%2C%20NJ%20%E2%80%93%20August%205,Google%20Cloud%2C%20Splunk%2C%20and%20Wiz">expansion of its cyber and data security ecosystem</a> through strategic integrations with several security partners, including Acante, Dasera, Google Cloud, Splunk, and Wiz.
These integrations are crucial in enhancing cyber resilience for joint customers across on-premises, hybrid, and cloud environments, from detecting potential threats or anomalies to identifying the location of sensitive data and speeding up clean recoveries.
On July 31, CVLT announced Microsoft 365 Backup Storage as an integrated component of Commvault&#xAE; Cloud Backup and Recovery for Microsoft 365. The Commvault Cloud platform, powered by Microsoft Azure, enables joint customers to deploy this integrated solution for enhanced cyber resilience while enabling single-pane-of-glass control that simplifies administration and delivers a low total cost of ownership (TCO).
Robust Financials
For the second quarter that ended June 30, 2024, CVLT's revenues increased 13.4% year-over-year to $224.67 million. Its gross margin rose 13.7% from the year-ago value to $184.88 million. Its non-GAAP income from operations grew 11% from the prior year's quarter to $48.30 million.
Additionally, the company's non-GAAP net income and earnings per share were $38.40 million and $0.85, compared to $32.53 million and $0.72 in the previous year's period, respectively. Its non-GAAP <a href="https://www.investopedia.com/terms/f/freecashflow.asp">free cash flow</a> was $43.83 million, up 15.7% year-over-year.
Favorable Analyst Estimates
Analysts expect CVLT's revenue for the second quarter (ending September 2024) to grow 9.9% year-over-year to $220.97 million. The consensus EPS estimate of $0.76 for the ongoing quarter indicates an improvement of 8.2% year-over-year. Further, the company has topped consensus revenue and EPS estimates in each of the trailing four quarters, which is impressive.
For the fiscal year ending March 2025, Street expects Commvault's revenue and EPS to increase 9.8% and 12.3% from the previous year to $921.31 million and $3.35, respectively. The company's revenue and EPS for the fiscal year 2026 are expected to grow 10% and 15.1% year-over-year to $1.01 billion and $3.85, respectively.
High Profitability
CVLT's trailing-12-month gross profit margin of 82% is 66.1% higher than the industry average of 49.36%. Likewise, the stock's trailing-12-month EBIT margin of 9.86% is 95.5% higher than the industry average of 5.05%. Moreover, its trailing-12-month net income margin of 20.19% is significantly higher than the industry average of 3.63%.
Further, the stock's trailing-12-month ROCE, ROTC, and ROTA of 77.04%, 22.33%, and 18.70% favorably compared to the industry averages of 4.41%, 2.76%, and 2.06%, respectively. Its trailing-12-month levered FCF margin of 24.55% is 132.8% higher than the industry average of 10.54%.
POWR Ratings Reflect Promise
CVLT's sound fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by taking into account 118 different factors, with each factor weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. CVLT has an A grade for Quality, consistent with its higher-than-industry profitability. In addition, the stock has a B grade for Growth and Sentiment, in sync with outstanding financial performance in the last reported quarter and optimistic analyst estimates.
Within the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry, CVLT is ranked #14 out of 129 stocks.
Beyond what I have stated above, we have also given CVLT grades for Value, Momentum, and Stability. Get all CVLT ratings <a href="https://stocknews.com/stock/CVLT/">here</a>.
Bottom Line
CVLT has consistently demonstrated its leadership in the cloud resilience and data protection space, bolstered by robust financial performance and strategic integrations with leading cloud and cybersecurity partners.
What truly sets Commvault apart from its industry peers is its ability to protect a wide range of workloads, deliver enterprise-grade data protection, offer simple and scalable recovery, and uniquely advance cyber resiliency—all within a single, unified platform.
Given outstanding financials, accelerating profitability, and a promising long-term outlook, CVLT could be an ideal buy for solid returns.
How Does Commvault Systems, Inc. (CVLT) Stack Up Against Its Peers?
While CVLT has an overall POWR Rating of B, investors could also check out these other stocks within the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry with an A (Strong Buy) rating: SS&amp;C Technologies Holdings Inc. (<a href="https://stocknews.com/stock/SSNC/">SSNC</a>), MarketWise Inc. (<a href="https://stocknews.com/stock/MKTW/">MKTW</a>), and Magic Software Enterprises Ltd. (<a href="https://stocknews.com/stock/MGIC/">MGIC</a>).
To explore more A or B-rated software stocks, <a href="https://stocknews.com/category/software-application/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
CVLT shares were unchanged in premarket trading Thursday. Year-to-date, CVLT has gained 88.37%, versus a 18.21% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Mangeet Kaur Bouns</h2> <img src='https:/wp-content/uploads/2022/01/Mangeet-Kaur-Bouns_Image-4.jpg' style="float:left; padding:5px;width:125px;">Mangeet's keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet's looks to help retail investors understand the underlying factors before making investment decisions.<a href="https://stocknews.com/authors/?author=mangeet-kaurbouns">More...</a>The post <a href=https://stocknews.com/news/cvlt-ssnc-mgic-mktw-could-commvault-systems-be-the-next-big-cloud-security-winner/>Could CommVault Systems Be the Next Big Cloud Security Winner?</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Could CommVault Systems Be the Next Big Cloud Security Winner?

MarketWise reports Q3 results

MarketWise in charts: Paid subscribers, billings, and ARPU show significant Y/Y declines in Q3

MarketWise declares $0.01 dividend

CVLT

MGIC

SSNC

Dividends

Press Releases

MarketWise Declares Dividend on Common Stock

MarketWise - Annual Report and Shareholder Letter

MarketWise - Quarterly Report and Shareholder Letter

MarketWise to Release Third Quarter 2024 Financial Results

MarketWise Reports Net Income of $22.7 Million and Net Revenue of $97.2 Million for Third Quarter 2024

Comments

Marketwise

Marketwise (MKTW) Forecast

Marketwise (NASDAQ:MKTW) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga